Samuel Mon-Wei Yu

1.1k total citations
34 papers, 830 citations indexed

About

Samuel Mon-Wei Yu is a scholar working on Nephrology, Immunology and Molecular Biology. According to data from OpenAlex, Samuel Mon-Wei Yu has authored 34 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 12 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Samuel Mon-Wei Yu's work include Renal Diseases and Glomerulopathies (9 papers), RNA Interference and Gene Delivery (5 papers) and Complement system in diseases (5 papers). Samuel Mon-Wei Yu is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), RNA Interference and Gene Delivery (5 papers) and Complement system in diseases (5 papers). Samuel Mon-Wei Yu collaborates with scholars based in United States, Germany and China. Samuel Mon-Wei Yu's co-authors include Joseph V. Bonventre, M. Wayne Flye, Lan Mao, Howard A. Rockman, Dennis Abraham, Ryan T. Strachan, Fadi Salem, Wei Chen, Gianluigi Pironti and Kenji Hanada and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Samuel Mon-Wei Yu

33 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Mon-Wei Yu United States 15 357 210 186 172 97 34 830
Dickson W.L. Wong Germany 14 254 0.7× 192 0.9× 286 1.5× 107 0.6× 43 0.4× 27 867
Sufyan G. Sayyed India 10 316 0.9× 193 0.9× 135 0.7× 102 0.6× 35 0.4× 12 706
M Takahashi Japan 11 316 0.9× 273 1.3× 111 0.6× 137 0.8× 47 0.5× 31 938
Kensuke Sasaki Japan 16 398 1.1× 328 1.6× 102 0.5× 137 0.8× 55 0.6× 53 881
Yulia Kiyan Germany 19 321 0.9× 66 0.3× 145 0.8× 115 0.7× 229 2.4× 31 923
Carolina Lavoz Spain 15 352 1.0× 171 0.8× 181 1.0× 98 0.6× 69 0.7× 26 738
Sanae Teshigawara Japan 16 341 1.0× 62 0.3× 202 1.1× 144 0.8× 180 1.9× 30 934
Yuta Takagaki Japan 10 293 0.8× 157 0.7× 57 0.3× 154 0.9× 86 0.9× 15 711
Panagiotis Kavvadas France 19 441 1.2× 225 1.1× 106 0.6× 80 0.5× 83 0.9× 33 840
Zhixia Song China 15 262 0.7× 220 1.0× 164 0.9× 111 0.6× 94 1.0× 21 710

Countries citing papers authored by Samuel Mon-Wei Yu

Since Specialization
Citations

This map shows the geographic impact of Samuel Mon-Wei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Mon-Wei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Mon-Wei Yu more than expected).

Fields of papers citing papers by Samuel Mon-Wei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Mon-Wei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Mon-Wei Yu. The network helps show where Samuel Mon-Wei Yu may publish in the future.

Co-authorship network of co-authors of Samuel Mon-Wei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Mon-Wei Yu. A scholar is included among the top collaborators of Samuel Mon-Wei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Mon-Wei Yu. Samuel Mon-Wei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sung, Li‐Chin, Hui‐Wen Chiu, Samuel Mon-Wei Yu, et al.. (2024). Thiazide diuretics versus loop diuretics in stage 3-5 CKD: impact on cardiorenal outcomes. Postgraduate Medicine. 136(7). 738–748. 1 indexed citations
2.
Jean‐Charles, Pierre‐Yves, Bipradas Roy, Samuel Mon-Wei Yu, et al.. (2024). USP20 deletion promotes eccentric cardiac remodeling in response to pressure overload and increases mortality. American Journal of Physiology-Heart and Circulatory Physiology. 327(5). H1257–H1271. 2 indexed citations
3.
Yu, Samuel Mon-Wei, Miguel Fribourg, Susan Hartzell, et al.. (2024). A Newly Identified Protective Role of C5a Receptor 1 in Kidney Tubules against Toxin-Induced Acute Kidney Injury. American Journal Of Pathology. 195(1). 126–142. 3 indexed citations
4.
Čumpelik, Arun, Samuel Mon-Wei Yu, Emilie K. Grasset, et al.. (2023). Cutting Edge: Neutrophil Complement Receptor Signaling Is Required for BAFF-Dependent Humoral Responses in Mice. The Journal of Immunology. 210(1). 19–23. 5 indexed citations
5.
Yu, Samuel Mon-Wei, et al.. (2023). Viral Glomerulopathy. SHILAP Revista de lepidopterología. 3(1). 148–154. 1 indexed citations
6.
Fu, Jia, Zeguo Sun, Xuan Wang, et al.. (2022). The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease. Kidney International. 102(6). 1291–1304. 84 indexed citations
7.
Budge, Kelly, Sergio Dellepiane, Samuel Mon-Wei Yu, & Paolo Cravedi. (2021). Complement, a Therapeutic Target in Diabetic Kidney Disease. Frontiers in Medicine. 7. 599236–599236. 25 indexed citations
8.
Ichimura, Takaharu, Mahmoud L. Nasr, Samuel Mon-Wei Yu, Yutaro Mori, & Joseph V. Bonventre. (2020). Kidney Injury Molecule 1 Is a Receptor for SARS-CoV-2. Journal of the American Society of Nephrology. 31(10S). 296–296. 1 indexed citations
9.
Manrique, Joaquín, Emilie Chan, Susan Hartzell, et al.. (2020). Circulating B Cells, Plasma Cells, and Treg Associate with ANCA Levels in ANCA-associated Vasculitis. Kidney International Reports. 6(2). 496–500. 5 indexed citations
10.
Yu, Samuel Mon-Wei, Jeremy S. Leventhal, & Paolo Cravedi. (2020). Totally tubular, dude: rethinking DKD pathogenesis in the wake of SGLT2i data. Journal of Nephrology. 34(3). 629–631. 6 indexed citations
11.
Yu, Samuel Mon-Wei, Pierre‐Yves Jean‐Charles, Dennis Abraham, et al.. (2018). The deubiquitinase ubiquitin–specific protease 20 is a positive modulator of myocardial β1-adrenergic receptor expression and signaling. Journal of Biological Chemistry. 294(7). 2500–2518. 20 indexed citations
12.
Yu, Samuel Mon-Wei, Anthony J. Bleyer, Leal Herlitz, et al.. (2017). Autosomal Dominant Tubulointerstitial Kidney Disease Due to MUC1 Mutation. American Journal of Kidney Diseases. 71(4). 495–500. 8 indexed citations
13.
Jean‐Charles, Pierre‐Yves, Samuel Mon-Wei Yu, Dennis Abraham, et al.. (2017). Mdm2 regulates cardiac contractility by inhibiting GRK2-mediated desensitization of β-adrenergic receptor signaling. JCI Insight. 2(17). 21 indexed citations
14.
Margenthaler, Julie A., et al.. (2003). Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft. Transplant International. 16(10). 713–720. 1 indexed citations
15.
Genden, Eric M., Susan E. Mackinnon, Samuel Mon-Wei Yu, Daniel A. Hunter, & M. Wayne Flye. (2001). Pretreatment With Portal Venous Ultraviolet B Irradiated Donor Alloantigen Promotes Donor‐Specific Tolerance to Rat Nerve Allografts. The Laryngoscope. 111(3). 439–447. 11 indexed citations
16.
17.
18.
Smith, Craig R., T. Mohanakumar, Yoshiaki Shimizu, et al.. (2000). BRIEF CYCLOSPORINE TREATMENT PREVENTS INTRATHYMIC (IT) TOLERANCE INDUCTION AND PRECIPITATES ACUTE REJECTION IN AN IT RAT CARDIAC ALLOGRAFT MODEL 1,2. Transplantation. 69(2). 294–294. 15 indexed citations
19.
Atchabahian, Arthur, et al.. (1998). Indefinite survival of peripheral nerve allografts after temporary Cyclosporine A immunosuppression. Restorative Neurology and Neuroscience. 13(3-4). 129–139. 21 indexed citations
20.
Flye, M. Wayne, et al.. (1987). Reversal of ischemic liver failure by intrasplenic liver cell transplantation. Journal of Pediatric Surgery. 22(12). 1212–1215. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dickson W.L. Wong Breakdown of academic impact, for papers by Sufyan G. Sayyed Breakdown of academic impact, for papers by M Takahashi Breakdown of academic impact, for papers by Kensuke Sasaki Breakdown of academic impact, for papers by Yulia Kiyan Breakdown of academic impact, for papers by Carolina Lavoz Breakdown of academic impact, for papers by Sanae Teshigawara Breakdown of academic impact, for papers by Yuta Takagaki Breakdown of academic impact, for papers by Panagiotis Kavvadas Breakdown of academic impact, for papers by Zhixia Song
Rankless by CCL
2026